Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-11

Clinical Trial Update: Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLC [Phase 2]

View source ↗

Summary

A phase 2 trial assessing induction therapy with vinorelbine and cisplatin followed by radiotherapy in patients with unresectable lung cancer has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Vinorelbine (Vinorelbine)

Snippet

Sponsor: Spanish Lung Cancer Group | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-01-11